The Missing Link Between Transforming G Proteins and Rho?

Total Page:16

File Type:pdf, Size:1020Kb

The Missing Link Between Transforming G Proteins and Rho? Oncogene (2001) 20, 1661 ± 1668 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Shigetomo Fukuhara1,2, Hiroki Chikumi1 and J Silvio Gutkind*,1 1Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland MD 20892-4340, USA Oncogene (2001) 20, 1661 ± 1668. aq, and a12 (Wilkie et al., 1992). The aq family of heterotrimeric G protein a subunits is coupled to Keywords: Rho; G proteins; Ras; signal transduction; phospholipase-C b to induce the hydrolysis of G protein-coupled receptors phosphatidylinositol bis phosphate, the consequent rise in the intracellular concentration of Ca2+, and the activation of protein kinase C, whereas the as and ai Introduction families are known to activate and inhibit adenylyl cyclase to increase and decrease the level of cyclic Many mitogens promote cell proliferation by acting AMP, respectively. ai proteins also regulate ion on cell surface receptors that either possess an channels, certain phospholipases and phosphodies- intrinsic protein-tyrosine kinase activity (Yarden et terases (Hamm, 1998). The targets for both members al., 1986) or interact with heterotrimeric GTP- of the a12 family, a12 and a13, were unknown until binding proteins (G proteins). The latter are recently. In addition, eleven-G protein g subunits and collectively known as G protein-coupled receptors ®ve G protein b subunits have been cloned so far and (GPCRs) and comprise the largest group of cell they regulate certain ion channels, phospholipase-C, surface molecules involved in signal transmission. and phosphatidylinositol-3 kinases (Clapham and With more than 1000 members, they are encoded by Neer, 1997). the biggest gene family in the human genome Through these G proteins subunits, GPCRs (Flower, 1999), and the importance and diversity regulate a diverse array of physiological functions of their physiological roles are directly supported by such as neurotransmission, chemoreception, photo- their link to a number of hereditary and acquired reception, metabolism, growth, and dierentiation. In diseases (Spiegel, 1996; Stadel et al., 1997). Further- addition to these physiological responses, there is more, these receptors and their ligands are the target also emerging evidence of the involvement of of over 50% of all current therapeutic agents aberrant GPCR function in cellular transformation (Flower, 1999). and oncogenesis (see Gutkind, 1998 for a recent GPCRs exhibit a common structural motif consisting review). In this regard, recent work suggests that the of seven membrane-spanning regions (Dohlman et al., Rho family of small GTP-binding proteins plays a 1987), and can be activated by a diverse array of central role in the regulation of cell proliferation by external stimuli, including growth factors, vasoactive GPCRs, and that the persistent activation of Rho- polypeptides, chemoattractants, neurotransmitters, hor- mediated pathways by heterotrimeric G proteins can mones, phospholipids, photons, odorants, and taste lead to cellular transformation. In this review, we ligands. In general, agonist binding provokes rapid will focus on recent eorts addressing the molecular conformational changes in the transmembrane a mechanisms by which GPCRs and G protein a helices, which result in the exposure of previously subunits activate Rho, with emphasis on their masked G protein binding sites in the intracellular contribution to the understanding on how this signal loops (Altenbach et al., 1996; Bourne, 1997; Wess, transducing system regulates normal and aberrant 1997). This causes the exchange of GDP for GTP cell growth. bound to the G protein a subunit, and GTP-bound a subunits or bg complexes then initiate intracellular signaling responses by acting on a variety of eector Transforming G protein coupled receptors molecules. To date, sixteen distinct mammalian G protein a subunits have been identi®ed and divided into Most oncogenes were discovered by virtue of their four families based on their sequence similarity: as, ai, ability to transform cells in culture or to induce tumorigenesis in experimental animals (Weinberg, 1985). They include activated tyrosine kinase growth factor receptors, their ligands, and aberrant versions of *Correspondence: JS Gutkind, molecules thought to participate in their growth- 2Current address: Division of Integrative Cell Biology, Department of Embryogenesis, Institute of Molecular Embryology and Genetics, promoting pathways (Aaronson, 1991). On the other Kumamoto University, Kumamoto 860-0811, Japan hand, the discovery of the mas oncogene provided the RGS-containing RhoGEFs S Fukuhara et al 1662 ®rst evidence that GPCRs can harbor transforming but behaves as a constitutively active Gq-coupled potential (Young et al., 1986). The natural agonist for receptor and, as predicted, is sucient to subvert the mas oncogene product is still unknown, but is likely normal growth control when expressed in cultured to be a serum component. Similarly, serotonin 1C ®broblasts (Arvanitakis et al., 1997). The KSHV ± receptors were shown to be oncogenic if ectopically GPCR can eectively activate signaling pathways expressed in NIH3T3 cells and activated by the typical of transforming receptors, and may represent serotonin present in the culture medium (Julius et al., a key molecule in the pathogenesis of Kaposi's 1989). Using a more de®ned experimental system, Sarcoma because of its central role in the promotion certain muscarinic receptor subtype were shown to of VEGF-driven angiogenesis and spindle cell prolif- transform NIH3T3 cells in a strictly agonist-dependent eration (Bais et al., 1998; Sodhi et al., 2000). As manner (Gutkind et al., 1991). Since neurotransmitter described in the accompanying review by Heasley acetylcholine, the natural agonist for these receptors, is (2001), there is also compelling evidence for a role of not present in serum, it was possible to correlate GPCRs in many human neoplasias, including small cell biochemical responses with the biological eects lung carcinoma, colon adenomas and carcinomas, elicited by an exogenously added agonist. This gastric hyperplasia and cancer, prostate cancer, and approach established that while Gq-coupled receptors pancreatic carcinoma, which express wild-type GPCRs (m1, m3, and m5), were highly transforming, Gi- that are persistently stimulated by tumor-released coupled receptors (m2 and m4), were without focus- agonists in an autocrine or paracrine fashion. Indeed, forming activity. Together, these ®ndings demonstrated the use of blocking antibodies and receptor antagonists that certain GPCRs could behave as potent agonist- has been shown to be eective in a variety of in vitro dependent oncogenes, and raised the possibility that and in vivo tumor models, which lends support to the activating mutations in GPCRs may render them potential causative role of GPCRs in these diseases transforming. Indeed, this was subsequently shown (Langdon et al., 1992; Sethi et al., 1992; Thomas et al., for the a1b G protein-linked receptor to noradrenaline 1992). It also provides the rationale for the develop- (Allen et al., 1991). In this case, speci®c point ment of novel treatment modalities in cancer therapy. mutations in the C-terminal juxtamembrane region of the third intracellular loop of the a1b receptor relieved the requirement of ligand activation for its transform- Transforming G proteins ing ability. Several GPCRs have now been cloned using The potent transforming potential of certain GPCRs standard transfection and tumorigenesis assays. and their likely contribution to human neoplasias Furthermore, the discovery of activated mutants of prompted many laboratories to explore the biological GPCRs in a variety of neoplastic diseases and consequences of expressing constitutively activate oncogenic viruses provided direct evidence of a role mutants of heterotrimeric G protein a subunits. These of these cell surface receptors and their coupled G experiments were possible due to the observation that proteins in cancerous growth. For example, activating all G protein a subunits exhibit a highly conserved mutations in TSH receptors were found in 30% of region, designated G-3 (Bourne et al., 1991), which is thyroid adenomas (Parma et al., 1993), and mutation- involved in binding and hydrolysis of GTP. This region ally activated LH receptors have been identi®ed in a includes a consensus sequence DVGGQ. Replacement form of familial male precocious puberty that results of the glutamine residue (Q) for leucine (L) in the from hyperplastic growth of Leydig cells (Shenker et corresponding sequence of the ras gene (codon 61) al., 1993). Reports are also available indicating that increases the steady-state levels of GTP-bound p21ras active mutants of FSH receptors are expressed in and unmasks its oncogenic potential (Barbacid, 1987). ovarian sex cord tumors and ovarian small cell Accordingly, constitutively activated Ga subunits (QL carcinoma (Kotlar et al., 1997), CCK-B receptors in mutants) were generated and tested for their ability to colorectal cancer (Hellmich et al., 2000), and Ca2+- transform rodent ®broblasts. In these initial studies, sensing receptors in a form of autosomal-dominant activated mutants of members of the Gas,Gai and Gaq hypocalcemia that is concomitant with a variety of family were found to provoke alterations in cell growth neoplasms (Ho et al., 1999).
Recommended publications
  • Dynamin Functions and Ligands: Classical Mechanisms Behind
    1521-0111/91/2/123–134$25.00 http://dx.doi.org/10.1124/mol.116.105064 MOLECULAR PHARMACOLOGY Mol Pharmacol 91:123–134, February 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW Dynamin Functions and Ligands: Classical Mechanisms Behind Mahaveer Singh, Hemant R. Jadhav, and Tanya Bhatt Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani Campus, Rajasthan, India Received May 5, 2016; accepted November 17, 2016 Downloaded from ABSTRACT Dynamin is a GTPase that plays a vital role in clathrin-dependent pathophysiology of various disorders, such as Alzheimer’s disease, endocytosis and other vesicular trafficking processes by acting Parkinson’s disease, Huntington’s disease, Charcot-Marie-Tooth as a pair of molecular scissors for newly formed vesicles originating disease, heart failure, schizophrenia, epilepsy, cancer, dominant ’ from the plasma membrane. Dynamins and related proteins are optic atrophy, osteoporosis, and Down s syndrome. This review is molpharm.aspetjournals.org important components for the cleavage of clathrin-coated vesicles, an attempt to illustrate the dynamin-related mechanisms involved phagosomes, and mitochondria. These proteins help in organelle in the above-mentioned disorders and to help medicinal chemists division, viral resistance, and mitochondrial fusion/fission. Dys- to design novel dynamin ligands, which could be useful in the function and mutations in dynamin have been implicated in the treatment of dynamin-related disorders. Introduction GTP hydrolysis–dependent conformational change of GTPase dynamin assists in membrane fission, leading to the generation Dynamins were originally discovered in the brain and identi- of endocytic vesicles (Praefcke and McMahon, 2004; Ferguson at ASPET Journals on September 23, 2021 fied as microtubule binding partners.
    [Show full text]
  • Crystal Structure of a Small G Protein in Complex with the Gtpase
    letters to nature of apolipoproteins2,12–14. However, our results show that the residues lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269, 2764– 2+ 2772 (1994). in the conserved acidic motif of LR5 are buried to participate in Ca 16. Innerarity, T. L., Pitas, R. E. & Mahley, R. W. Binding of arginine-rich (E) apoprotein after coordination, instead of being exposed on the surface of the domain recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254, 4186–4190 (1979). (Fig. 4a). Although lipoprotein uptake by members of the LDLR 17. Otwinowski, Z. & Minor, W. Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) family may involve an electrostatic component, perhaps through 556–562 (SERC Daresbury Laboratory, Warrington, UK, 1993). association of the lipoproteins with cell-surface proteoglycans15, the 18. CCP4. The SERC (UK) Collaborative Computing Project No. 4 A Suite of Programs for Protein Crystallography (SERC Daresbury Laboratory, Warrington, UK, 1979). LR5 structure demonstrates that the primary role for the conserved 19. Cowtan, K. D. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 34–38 (1994). acidic residues in LDL-A modules is structural. It has been noted 20. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 previously that only lipid-associated apolipoproteins bind with (1991). 16 high affinity to the LDLR ; the LR5 structure suggests an alternative 21.
    [Show full text]
  • Ras Gtpase Chemi ELISA Kit Catalog No
    Ras GTPase Chemi ELISA Kit Catalog No. 52097 (Version B3) Active Motif North America 1914 Palomar Oaks Way, Suite 150 Carlsbad, California 92008, USA Toll free: 877 222 9543 Telephone: 760 431 1263 Fax: 760 431 1351 Active Motif Europe Waterloo Atrium Drève Richelle 167 – boîte 4 BE-1410 Waterloo, Belgium UK Free Phone: 0800 169 31 47 France Free Phone: 0800 90 99 79 Germany Free Phone: 0800 181 99 10 Telephone: +32 (0)2 653 0001 Fax: +32 (0)2 653 0050 Active Motif Japan Azuma Bldg, 7th Floor 2-21 Ageba-Cho, Shinjuku-Ku Tokyo, 162-0824, Japan Telephone: +81 3 5225 3638 Fax: +81 3 5261 8733 Active Motif China 787 Kangqiao Road Building 10, Suite 202, Pudong District Shanghai, 201315, China Telephone: (86)-21-20926090 Hotline: 400-018-8123 Copyright 2021 Active Motif, Inc. www.activemotif.com Information in this manual is subject to change without notice and does not constitute a commit- ment on the part of Active Motif, Inc. It is supplied on an “as is” basis without any warranty of any kind, either explicit or implied. Information may be changed or updated in this manual at any time. This documentation may not be copied, transferred, reproduced, disclosed, or duplicated, in whole or in part, without the prior written consent of Active Motif, Inc. This documentation is proprietary information and protected by the copyright laws of the United States and interna- tional treaties. The manufacturer of this documentation is Active Motif, Inc. © 2021 Active Motif, Inc., 1914 Palomar Oaks Way, Suite 150; Carlsbad, CA 92008.
    [Show full text]
  • Molecular Biology of Neuronal Voltage-Gated Calcium Channels
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 30, No 3, 123-130, September 1998 Molecular biology of neuronal voltage-gated calcium channels Hemin Chin and is capable of directing expression of calcium channel activity in heterologous expression systems. In the central Genetics Research Branch, Division of Basic and Clinical Neuroscience Research, nervous system (CNS), VGCCs are expressed by five National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, distinct a1 subunit genes (α1A, α1B, α1C, α1D and α1E), U.S.A. which exhibit further variations due to alternative splicing of the primary RNA transcripts. The α1C and, α1D su b u n i t Accepted 3 August 1998 genes encode dihydropyridine (DHP)-sensitive L-type channels, while the three other α1 subunit genes (α1A, α1B and α1E) give rise to DHP-insensitive P/Q-, N- and R-type channels, respectively. The α2 and δ s u b u n i t proteins are produced by proteolytic cleavage of a larger precursor produced by the single α2-δ gene (Table 1). Introduction Three alternatively spliced variants of the α2 subunit are expressed in a tissue-specific manner. Two variants Calcium ions are important intracellular messengers have been isolated from the brain and skeletal muscle mediating a number of neuronal functions including neuro- (Kim et al., 1992; Williams et al., 1992), and a distinct transmitter release, neurosecretion, neuronal excitation, third splice variant which is expressed in glial cells has survival of eurons, and regulation of gene expression. been recently identified (Puro et al., 1996). In addition to The entry of calcium across the plasmamembrane in the gene encoding the skeletal muscle β subunit, three response to membrane depolarization or activation of 1 other β subunit genes (β2, β3 and β4) have been isolated neurotransmitter receptors represents a major pathway thus far.
    [Show full text]
  • Plasma Membrane Repairs by Small Gtpase Rab3a
    Published June 20, 2016 JCB: SpotlightReview Plasma membrane repairs by small GTPase Rab3a Camilla Raiborg1,2 and Harald Stenmark1,2 1Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, N-0379 Oslo, Norway 2Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, N-0379 Oslo, Norway Lysosomes fuse with the plasma membrane to help repair in lysosome-mediated PM repair has not been addressed. In this membrane lesions, but how they are positioned close to issue, Encarnação et al. screened siRNAs that target human Rab GTPases to identify Rabs involved in translocating lysosomes to these lesions is not fully understood. Now, Encarnação et the PM in response to the Ca2+ ionophore ionomycin and in the al. (2016. J. Cell Biol. http ://dx .doi .org /10 .1083 /jcb repair of PM holes caused by the bacterial toxin Streptolysin-O .201511093) demonstrate that the lysosomal GTPase (Encarnação et al., 2016). One of the most prominent hits in this Rab3a and its effectors orchestrate lysosome positioning screen was Rab3a, a GTPase previously characterized mainly in the regulation of Ca2+-induced exocytosis of synaptic vesicles and plasma membrane repair. in neurons and of dense-core vesicles in endocrine cells (Gep- pert et al., 1994; Johannes et al., 1994). Even though Rab3a is Downloaded from When the plasma membrane (PM) of eukaryotic cells is predominantly expressed in neurons and endocrine tissues, En- wounded by mechanical damage or by bacterial toxins, the carnação et al. (2016) were able to detect its expression in HeLa wound is normally repaired within seconds by mechanisms cells and melanocytes.
    [Show full text]
  • Chemical Neurotransmission
    Cambridge University Press 978-1-107-02598-1 — Stahl's Essential Psychopharmacology 4th Edition Excerpt More Information Chapter1 Chemical neurotransmission Anatomical versus chemical basis of Beyond the second messenger to a neurotransmission 1 phosphoprotein cascade triggering gene 16 Principles of chemical neurotransmission 5 expression Neurotransmitters 5 How neurotransmission triggers gene 18 Neurotransmission: classic, retrograde, expression 18 and volume 6 Molecular mechanism of gene expression Excitation–secretion coupling 8 Epigenetics 24 Signal transduction cascades 9 What are the molecular mechanisms 24 Overview 9 of epigenetics? Forming a second messenger 11 How epigenetics maintains or changes the status quo 26 Beyond the second messenger to phosphoprotein messengers 13 Summary 26 Modern psychopharmacology is largely the story of neurons, not unlike millions of telephone wires chemical neurotransmission. To understand the actions within thousands upon thousands of cables. The ana- of drugs on the brain, to grasp the impact of diseases tomically addressed brain is thus a complex wiring upon the central nervous system, and to interpret the diagram, ferrying electrical impulses to wherever behavioral consequences of psychiatric medicines, the “wire” is plugged in (i.e., at a synapse). Synapses one must be fluent in the language and principles of canformonmanypartsofaneuron,notjustthe chemical neurotransmission. The importance of this dendrites as axodendritic synapses, but also on the fact cannot be overstated for the student of psychophar- soma as axosomatic synapses, and even at the begin- macology. This chapter forms the foundation for the ning and at the end of axons (axoaxonic synapses) entire book, and the roadmap for one’s journey through (Figure 1-2).
    [Show full text]
  • G Protein Regulation of MAPK Networks
    Oncogene (2007) 26, 3122–3142 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW G Protein regulation of MAPK networks ZG Goldsmith and DN Dhanasekaran Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA G proteins provide signal-coupling mechanisms to hepta- the a-subunits has been used as a basis for the helical cell surface receptors and are criticallyinvolved classification of G proteins into Gs,Gi,Gq and G12 in the regulation of different mitogen-activated protein families in which the a-subunits that show more than kinase (MAPK) networks. The four classes of G proteins, 50% homology are grouped together (Simon et al., defined bythe G s,Gi,Gq and G12 families, regulate 1991). In G-protein-coupled receptor (GPCR)-mediated ERK1/2, JNK, p38MAPK, ERK5 and ERK6 modules by signaling pathways, ligand-activated receptors catalyse different mechanisms. The a- as well as bc-subunits are the exchange of the bound GDP to GTP in the a-subunit involved in the regulation of these MAPK modules in a following which the GTP-bound a-subunit disassociate context-specific manner. While the a- and bc-subunits from the receptor as well as the bg-subunit. The GTP- primarilyregulate the MAPK pathwaysvia their respec- bound a-subunit and the bg-subunit stimulate distinct tive effector-mediated signaling pathways, recent studies downstream effectors including enzymes, ion channels have unraveled several novel signaling intermediates and small GTPase, thus regulating multiple signaling including receptor tyrosine kinases and small GTPases pathways including those involved in the activation of through which these G-protein subunits positivelyas well mitogen-activated protein kinase (MAPK) modules as negativelyregulate specific MAPK modules.
    [Show full text]
  • Part III: Modeling Neurotransmission – a Cholinergic Synapse
    Part III: Modeling Neurotransmission – A Cholinergic Synapse Operation of the nervous system is dependent on the flow of information through chains of neurons functionally connected by synapses. The neuron conducting impulses toward the synapse is the presynaptic neuron, and the neuron transmitting the signal away from the synapse is the postsynaptic neuron. Chemical synapses are specialized for release and reception of chemical neurotransmitters. For the most part, neurotransmitter receptors in the membrane of the postsynaptic cell are either 1.) channel-linked receptors, which mediate fast synaptic transmission, or 2.) G protein-linked receptors, which oversee slow synaptic responses. Channel-linked receptors are ligand-gated ion channels that interact directly with a neurotransmitter and are called ionotropic receptors. Alternatively, metabotropic receptors do not have a channel that opens or closes but rather, are linked to a G-protein. Once the neurotransmitter binds to the metabotropic receptor, the receptor activates the G-protein which, in turn, goes on to activate another molecule. 3a. Model the ionotropic cholinergic synapse shown below. Be sure to label all of the following: voltage-gated sodium channel, voltage-gated potassium channel, neurotransmitter, synaptic vesicle, presynaptic cell, postsynaptic cell, potassium leak channel, sodium-potassium pump, synaptic cleft, acetylcholine receptor, acetylcholinesterase, calcium channel. When a nerve impulse (action potential) reaches the axon terminal, it sets into motion a chain of events that triggers the release of neurotransmitter. You will next model the events of neurotransmission at a cholinergic synapse. Cholinergic synapses utilize acetylcholine as the chemical of neurotransmission. MSOE Center for BioMolecular Modeling Synapse Kit: Section 3-6 | 1 Step 1 - Action potential arrives at the Step 2 - Calcium channels open in the terminal end of the presynaptic cell.
    [Show full text]
  • Regulation of Neuronal Communication by G Protein-Coupled Receptors ⇑ Yunhong Huang, Amantha Thathiah
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 589 (2015) 1607–1619 journal homepage: www.FEBSLetters.org Review Regulation of neuronal communication by G protein-coupled receptors ⇑ Yunhong Huang, Amantha Thathiah VIB Center for the Biology of Disease, Leuven, Belgium Center for Human Genetics (CME) and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven (KUL), Leuven, Belgium article info abstract Article history: Neuronal communication plays an essential role in the propagation of information in the brain and Received 31 March 2015 requires a precisely orchestrated connectivity between neurons. Synaptic transmission is the mech- Revised 5 May 2015 anism through which neurons communicate with each other. It is a strictly regulated process which Accepted 5 May 2015 involves membrane depolarization, the cellular exocytosis machinery, neurotransmitter release Available online 14 May 2015 from synaptic vesicles into the synaptic cleft, and the interaction between ion channels, G Edited by Wilhelm Just protein-coupled receptors (GPCRs), and downstream effector molecules. The focus of this review is to explore the role of GPCRs and G protein-signaling in neurotransmission, to highlight the func- tion of GPCRs, which are localized in both presynaptic and postsynaptic membrane terminals, in reg- Keywords: G protein-coupled receptors ulation of intrasynaptic and intersynaptic communication, and to discuss the involvement of G-proteins astrocytic GPCRs in the regulation of neuronal communication. Neuronal communication Ó 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. Synaptic transmission Signaling Astrocytes Neurons Autoreceptors Neurotransmitters 1.
    [Show full text]
  • RIM-BP2 Primes Synaptic Vesicles Via Recruitment of Munc13-1 At
    RESEARCH ARTICLE RIM-BP2 primes synaptic vesicles via recruitment of Munc13-1 at hippocampal mossy fiber synapses Marisa M Brockmann1†, Marta Maglione2,3,4†, Claudia G Willmes5†, Alexander Stumpf6, Boris A Bouazza1, Laura M Velasquez6, M Katharina Grauel1, Prateep Beed6, Martin Lehmann3, Niclas Gimber6, Jan Schmoranzer4, Stephan J Sigrist2,4,5*, Christian Rosenmund1,4*, Dietmar Schmitz4,5,6* 1Institut fu¨ r Neurophysiologie, Charite´ – Universita¨ tsmedizin Berlin, corporate member of Freie Universita¨ t Berlin, Humboldt-Universita¨ t zu Berlin, and Berlin Institute of Health, Berlin, Germany; 2Freie Universita¨ t Berlin, Institut fu¨ r Biologie, Berlin, Germany; 3Leibniz-Forschungsinstitut fu¨ r Molekulare Pharmakologie (FMP), Berlin, Germany; 4NeuroCure Cluster of Excellence, Berlin, Germany; 5DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany; 6Neuroscience Research Center, Charite´ – Universita¨ tsmedizin Berlin, corporate member of Freie Universita¨ t Berlin, Humboldt-Universita¨ t zu Berlin, and Berlin Institute of Health, Berlin, Germany Abstract All synapses require fusion-competent vesicles and coordinated Ca2+-secretion coupling for neurotransmission, yet functional and anatomical properties are diverse across *For correspondence: different synapse types. We show that the presynaptic protein RIM-BP2 has diversified functions in [email protected] (SJS); neurotransmitter release at different central murine synapses and thus contributes to synaptic [email protected] diversity. At hippocampal pyramidal CA3-CA1 synapses, RIM-BP2 loss has a mild effect on (CR); neurotransmitter release, by only regulating Ca2+-secretion coupling. However, at hippocampal [email protected] (DS) mossy fiber synapses, RIM-BP2 has a substantial impact on neurotransmitter release by promoting †These authors contributed vesicle docking/priming and vesicular release probability via stabilization of Munc13-1 at the active equally to this work zone.
    [Show full text]
  • G-Protein-Coupled Receptors in CNS: a Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
    cells Review G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits Shofiul Azam 1 , Md. Ezazul Haque 1, Md. Jakaria 1,2 , Song-Hee Jo 1, In-Su Kim 3,* and Dong-Kug Choi 1,3,* 1 Department of Applied Life Science & Integrated Bioscience, Graduate School, Konkuk University, Chungju 27478, Korea; shofi[email protected] (S.A.); [email protected] (M.E.H.); md.jakaria@florey.edu.au (M.J.); [email protected] (S.-H.J.) 2 The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010, Australia 3 Department of Integrated Bioscience & Biotechnology, College of Biomedical and Health Science, and Research Institute of Inflammatory Disease (RID), Konkuk University, Chungju 27478, Korea * Correspondence: [email protected] (I.-S.K.); [email protected] (D.-K.C.); Tel.: +82-010-3876-4773 (I.-S.K.); +82-43-840-3610 (D.-K.C.); Fax: +82-43-840-3872 (D.-K.C.) Received: 16 January 2020; Accepted: 18 February 2020; Published: 23 February 2020 Abstract: Neurodegenerative diseases are a large group of neurological disorders with diverse etiological and pathological phenomena. However, current therapeutics rely mostly on symptomatic relief while failing to target the underlying disease pathobiology. G-protein-coupled receptors (GPCRs) are one of the most frequently targeted receptors for developing novel therapeutics for central nervous system (CNS) disorders. Many currently available antipsychotic therapeutics also act as either antagonists or agonists of different GPCRs. Therefore, GPCR-based drug development is spreading widely to regulate neurodegeneration and associated cognitive deficits through the modulation of canonical and noncanonical signals.
    [Show full text]
  • The Mechanisms and Functions of Spontaneous Neurotransmitter Release
    REVIEWS The mechanisms and functions of spontaneous neurotransmitter release Ege T. Kavalali Abstract | Fast synaptic communication in the brain requires synchronous vesicle fusion that is evoked by action potential-induced Ca2+ influx. However, synaptic terminals also release neurotransmitters by spontaneous vesicle fusion, which is independent of presynaptic action potentials. A functional role for spontaneous neurotransmitter release events in the regulation of synaptic plasticity and homeostasis, as well as the regulation of certain behaviours, has been reported. In addition, there is evidence that the presynaptic mechanisms underlying spontaneous release of neurotransmitters and their postsynaptic targets are segregated from those of evoked neurotransmission. These findings challenge current assumptions about neuronal signalling and neurotransmission, as they indicate that spontaneous neurotransmission has an autonomous role in interneuronal communication that is distinct from that of evoked release. 10–13 Docked vesicles Our current insights into the mechanisms under­lying relatively intact . Thus, although these experiments Synaptic vesicles that are synaptic transmission originate from experiments that proved the vesicular hypothesis of neurotransmitter tethered to the presynaptic were conducted in the 1950s by Bernard Katz and col- release, they raised the question of whether spontane- membrane or the active zone leagues1–3 (FIG. 1). A key aspect of these studies was the ous release events originate from the same vesicular traf- structure. According to current discovery of spontaneous neurotransmitter release ficking pathway as evoked neurotransmission14. Recent views, not all docked vesicles are fully primed for fusion and events, which seemed to occur in discrete ‘quantal’ advances in our understanding support the autonomous release of neurotransmitter. packets (FIG.
    [Show full text]